- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in glenmark
Pharma Such As Glenmark, Sun Pharma, Dr Reddy's Recall Drugs In US
As per the USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. "As per the USFDA, Sun Pharma is recalling 9,552 bottles of epilepsy treatment drug Divalproex Sodium delayed-release tablets due to "Failed Dissolution Specifications"
Read More
Lupin, Glenmark, Dr Reddy's Recall Products In US
According to industry estimates, the US generic drug market was estimated to be around USD 115.2 billion in 2019
Read More
Glenmark To Conduct Clinical Trials Of Its Molecule On Cancer Patients
Glenmark Pharmaceuticals said its unit has received approval from the DCGI to conduct phase 1 clinical trials of its novel molecule on patients with advanced solid tumors
Read More
Glenmark Life Sciences Shares List With Over 4 % Gain
The stock listed at Rs 751.10, a gain of 4.31 per cent from the issue price on BSE. As trade progressed, it jumped 11.10 per cent to Rs 799.95.
Read More
Glenmark Life Sciences To Invest Rs 600 Cr To Double Capacity In Four Years
Glenmark Life Sciences is into select high value, non-commoditised APIs in chronic therapeutic areas like the cardiovascular, central nervous system, pain management and diabetes, apart from gastro-intestinal disorders, anti-infectives etc.
Read More
Glenmark Life Sciences IPO To Open On Jul 27; Price Band Set At Rs 695-720/Share
The public issue will have fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma.
Read More
Glenmark Life Sciences IPO To Open Next Week
Glenmark Life Sciences had filed the red herring prospectus for the offer with the Registrar of Companies, Pune and it was taken on record by the ROC the next day, Glenmark Pharma said in a BSE filing.
Read More
Glenmark Pharma Launches COPD Treatment Inhaler In UK
Glenmark's subsidiary Glenmark Pharmaceuticals Europe Ltd had entered into a strategic and exclusive in-licensing arrangement for marketing generic Tiotropium Bromide DPI in Western Europe and the UK in August 2018.
Read More
Glenmark Says Interim Data From Study Supports Favipiravir's Safety, Effectiveness
Glenmark received restricted emergency use approval from India's drug regulator for FabiFlu for the treatment of mild to moderate COVID-19.
Read More
Glenmark Q4 Net Profit Up 6 % At Rs 233.87 Cr
The company's revenue from operations stood at Rs 10,943.9 crore for the fiscal ended March 2021. It was Rs 10,641 crore in 2019-20
Read More
Glenmark Pharma Gets USFDA Nod For Icatibant Injection
The drug firm said its current portfolio consists of 172 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications are pending approval with the USFDA.
Read More
Glenmark Pharma To Launch Its Nasal Spray Ryaltris In EU
Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age.
Read MoreGlenmark receives one ANDA approval and two tentative ANDA approvals - Tadalafil Gabapentin Enacarbil and Apremilast
Glenmark receives one ANDA approval and two tentative ANDA approvals - Tadalafil Gabapentin Enacarbil and Apremilast
Read MoreGlenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India
Read MoreGlenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe
Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe
Read More